Prospective study of methotrexate treatment for rheumatoid arthritis treated legitimately according to the government recommended 8 mg/week dose.

Hashiramoto, Akira; Shiozawa, Kazuko; Tanaka, Yasushi; Yamane, Takashi; Murata, Miki; Tanaka, Chihiro; Terashima, Yasuhiro; Koyama, Kozo; Nakagawa, Natsuko; Abe, Shuji; Yoshihara, Rhosuke; Saegusa, Yasuhiro; Tsumiyama, Ken; Komai, Koichiro; Sakai, Yoshitada; Shiozawa, Shunichi

Hashiramoto, Akira; Shiozawa, Kazuko; Tanaka, Yasushi; Yamane, Takashi; Murata, Miki; Tanaka, Chihiro; Terashima, Yasuhiro; Koyama, Kozo; Nakagawa, Natsuko; Abe, Shuji; Yoshihara, Rhosuke; Saegusa, Yasuhiro; Tsumiyama, Ken; Komai, Koichiro; Sakai, Yoshitada; Shiozawa, Shunichi.

Affiliation

Hashiramoto A; The Center for Rheumatic Diseases, Kobe University Hospital, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.

Mod Rheumatol ; 19(6): 637-42, 2009.

Article in En | MEDLINE | ID: mdl-19626390

Subject(s)

Arthritis, Rheumatoid/drug therapy; Methotrexate/therapeutic use; Adolescent; Adult; Aged; Aged, 80 and over; Antirheumatic Agents/therapeutic use; Disease Progression; Female; Humans; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Methotrexate Type of study: Observational_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Mod Rheumatol Year: 2009 Document type: Article Affiliation country: Japan Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google